This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for a license and warranty for a PromethION 48 DNA/RNA sequencing system, with a period of performance through October 27, 2029. Oxford Nanopore Technologies has secured multiple prime contracts and...
This is a $120,000.00 firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization. The contract provides a software license and device warranty for a Nanopore PromethION long-read sequencer to support genomic research at the Center of Alzheimer's Disease and Related Dementias. There is no set-aside designation for this award. The...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $20,000 purchase order to Oxford Nanopore Technologies Inc. for SOFTWARE LICENSE AND DEVICE WARRANTY SERVICES - PROMETHION-24 SEQUENCER. Oxford Nanopore Technologies Inc. will provide software licenses and device warranty services for its PromethION-24 sequencer under the firm fixed price contract. Performance will take place in Baltimore, Maryland over a one year period from August...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...
Oxford Nanopore Technologies Inc. was awarded a $555,600 firm-fixed-price purchase order by the National Institutes of Health's National Institute on Aging to provide Oxford Nanopore Long Read Sequencing Kits. The contract calls for one PromethION 48 Starter Pack and one PromethION Flow Cell 72 pack, to be delivered within six months to the place of performance in Cambridge, Massachusetts. The solicitation sought quotes for these long read sequencing products and services to support research...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Oxford Nanopore Technologies Inc. for the purpose of purchasing long read sequencing on Oxford Nanopore manufactured sequencing systems. The contract has a potential value of $130,236.00 and a completion date of June 29, 2021. The parent company of the awardee is Oxford Nanopore Technologies PLC. There was no set-aside designation...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $185,835 firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for the delivery of PromethION flow cell packs for long-read DNA and RNA/cDNA sequencing. Per the solicitation, the Government sought these products and associated packaging, marking, shipping, and delivery services to 251 Bayview Blvd in Baltimore, Maryland within 90 days of order receipt. As specified,...
This is a firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Aging to Oxford Nanopore Technologies Inc., a division of the parent company Oxford Nanopore Technologies PLC. The $355,400 contract is for the provision of full-length RNA sequencing supplies to support the work of the National Institute on Aging. The contract has a completion date of June 15, 2022 and was originally awarded on September 16,...
This is a $243,996.00 firm-fixed price purchase order awarded by the National Institute on Aging, a component of the National Institutes of Health, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the provision of reagents to be used in long-read DNA and RNA sequencing on Oxford Nanopore's proprietary sequencing platforms at the Center for Alzheimer's Disease and Related Dementias. This requirement was originally market researched...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $3 million firm fixed price purchase order to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, to provide long read sequencing kits to the Laboratory of Neurogenetics for neurodegenerative disease research. The two month contract will support the laboratory's efforts to advance understanding of conditions such as Alzheimer's and Parkinson's diseases....
This firm fixed-price purchase order is valued at $30,000 and was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Oxford Nanopore Technologies Inc. The order is for a software license and device warranty to support the Nanopore Promethion Long Read Sequencer serial number P48_051 located at the NIH in Bethesda, Maryland. The sequencing platform will be used over the period of performance from July 2023 to July 2024 by the NIH's Laboratory of Neurogenetics and Center for Alzheimer's Disease and Related Dementias to support their research. No subcontractors or set-aside designations were identified.